IBM and Teva Pharmaceutical Industries Ltd., are expanding their global e-Health alliance to focus on the discovery of new treatment …
The company on Thursday said the Placing Shares are being offered by an accelerated bookbuild. Zeus Capital and N+1 Singer will be acting as joint bookrunners in connection with the Bookbuild, Quantum Pharma has said.
GW Pharmaceuticals plc has announced leaving AIM and canceling trading in London, to continue trading only on NASDAQ.
Teva Pharmaceutical has gotten a positive opinion from Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), recommending an indication extension of Trisenox (arsenic trioxide).
Quantum Pharma names new CEO and makes other board changes
Allergan announced that Sweden has received the Marketing Authorisation for BELKYRA (deoxycholic acid) after being granted approval by the Swedish Medical Products Agency (MPA).
Pfizer said on Thursday it would sell its global infusion therapy business, part of its $15 billion (11.8 billion pounds) Hospira acquisition last year, to ICU Medical Inc for $1 billion in cash and stock.